Myomo Execs to Present at H.C. Wainwright Conference Amid Wearable Robotics Push
Event summary
- Myomo CEO Paul Gudonis and CFO David Henry to present at H.C. Wainwright 28th Annual Global Investment Conference on September 14-16, 2026.
- Fireside chat scheduled for September 16, 2026, at 10:30 a.m. ET with Sean Lee, VP of Equity Research.
- On-demand presentation available starting September 11, 2026, at 7:00 a.m. ET.
- Myomo focuses on wearable medical robotics for neurological disorders and upper-limb paralysis.
The big picture
Myomo's presentation at the H.C. Wainwright conference underscores the growing interest in wearable medical robotics, particularly for patients with neurological disorders. The company's focus on restoring arm and hand function positions it within a niche but expanding sector of healthcare innovation. As wearable technology becomes more integrated into medical treatments, Myomo's ability to differentiate its MyoPro product line will be crucial for long-term success.
What we're watching
- Market Expansion
- How Myomo's participation in high-profile investor conferences will affect its visibility and potential partnerships in the wearable medical robotics space.
- Product Adoption
- Whether the company can sustain growth in MyoPro adoption among patients with neurological disorders and upper-limb paralysis.
- Financial Performance
- The pace at which Myomo can translate investor interest into tangible financial results and revenue growth.